Research paperNovel symmetric bis-benzimidazole (cas 16656-27-2)s: Synthesis, DNA/RNA binding and antitrypanosomal activity

Add time:08/15/2019    Source:sciencedirect.com

The novel benzimidazol-2-yl-fur-5-yl-(1,2,3)-triazolyl dimeric series with aliphatic and aromatic central linkers was successfully prepared with the aim of assessing binding affinity to DNA/RNA and antitrypanosomal activity. UV–Visible spectroscopy, thermal denaturation showed interaction of heterocyclic bis-amidines with ctDNA. Circular dichroism studies indicated uniform orientation of heterocyclic bis-amidines along the chiral double helix axis, revealing minor groove binding as the dominant binding mode. The amidino fragment and 1,4-bis(oxymethylene)phenyl spacer were the main determinants of activity against Trypanosoma brucei. The bis-benzimidazole imidazoline 15c, which had antitrypanosomal potency in the submicromolar range and DNA interacting properties, emerged as a candidate for further structural optimization to obtain more effective agents to combat trypanosome infections.

We also recommend Trading Suppliers and Manufacturers of bis-benzimidazole (cas 16656-27-2). Pls Click Website Link as below: cas 16656-27-2 suppliers

Prev:Detection and estimation of sedoheptulose and octulose mono- and bisphosphates in extracts of rat liver
Next:Fabrication of poly(bis-benzimidazole (cas 16656-27-2) imide) fibers with enhanced mechanical properties and high limit oxygen indexes)